Cost Is the Biggest Barrier to Zavzpret Adherence

You've determined that Zavzpret (Zavegepant) is the right acute migraine treatment for your patient. The clinical rationale is sound — it's the only intranasal CGRP receptor antagonist available, ideal for patients who can't tolerate triptans, have cardiovascular contraindications, or struggle with oral medications during attacks. But then your patient calls back: they can't afford it.

This scenario plays out daily across practices. At a cash price of $800–$1,100 for a pack of 8 nasal spray devices, Zavzpret presents a significant financial barrier. Even with insurance, prior authorization delays and high copays can derail treatment plans. As a prescriber, understanding the savings landscape and integrating cost conversations into your workflow can make the difference between a patient who fills their prescription and one who doesn't.

What Your Patients Are Paying

Understanding the cost landscape helps you set expectations and guide patients toward the right resources:

• Cash price (uninsured): $800–$1,100 per pack of 8 single-dose nasal spray devices. At this price, each migraine attack treated costs roughly $100–$138.
• Commercial insurance with coverage: Copays vary widely — from $0 with a manufacturer savings card to $50–$150+ per fill, depending on formulary tier and plan design.
• Commercial insurance without coverage: Some plans exclude Zavzpret or place it on a non-preferred specialty tier, resulting in copays of $200–$500+.
• Medicare Part D: Coverage varies by plan. Patients in the coverage gap ("donut hole") face significant out-of-pocket costs. Manufacturer savings cards are not valid for Medicare patients.
• Medicaid: Coverage varies by state. Manufacturer savings cards are also not valid for Medicaid patients.

The financial impact is real. A patient with 4–8 migraine attacks per month may need multiple packs, compounding cost pressures and often leading to rationing or non-adherence.

Manufacturer Savings Programs

Pfizer Zavzpret Savings Card

This is the most impactful tool for commercially insured patients:

• Eligibility: Commercially insured patients with a valid Zavzpret prescription. Not valid for patients insured by Medicare, Medicaid, Tricare, or other government programs.
• Benefit: Eligible patients may pay as little as $0 per prescription, with a maximum savings benefit per fill.
• Enrollment: Patients can enroll at the Zavzpret website or through their pharmacy. Some offices keep enrollment cards on hand to give patients at the point of prescribing.
• Duration: Typically valid for 12 months, renewable.

Clinical tip: Provide the savings card information at the same time you write the prescription. If the patient leaves your office without it, the chance of them researching it independently drops significantly.

Pfizer RxPathways (Patient Assistance Program)

For uninsured or underinsured patients who meet income eligibility criteria:

• Eligibility: U.S. residents who are uninsured, functionally underinsured, or enrolled in Medicare and facing financial hardship. Income limits apply (typically at or below 400% of the Federal Poverty Level, though Pfizer may adjust criteria).
• Benefit: Zavzpret may be provided at no cost to qualifying patients.
• Enrollment: Patients apply through pfizerrxpathways.com or by calling the Pfizer RxPathways phone line. Provider documentation (prescription and sometimes a brief letter of medical necessity) is typically required.
• Processing time: 2–4 weeks for initial enrollment. Once approved, medication is shipped directly to the patient or the prescriber's office.

Clinical tip: Designate a staff member (medical assistant, prior authorization specialist, or social worker) to handle PAP applications. This removes the burden from the patient and dramatically improves enrollment rates.

Coupon and Discount Cards

For patients who don't qualify for manufacturer programs or need a bridge while waiting for prior authorization:

• GoodRx — Shows pricing at nearby pharmacies and offers discount coupons that may reduce the cash price. Visit goodrx.com.
• SingleCare — Another coupon platform that may offer discounts at participating pharmacies.
• RxSaver — Compares prices across pharmacies and provides savings cards.
• Optum Perks — Discount program available at most major pharmacy chains.

Important caveat: For a high-cost branded specialty product like Zavzpret, coupon cards typically provide modest discounts compared to the manufacturer savings card. They're most useful as a backup option, not a primary savings strategy.

Generic Alternatives and Therapeutic Substitution

As of 2026, there is no generic version of Zavzpret (Zavegepant). However, if cost is prohibitive, therapeutic alternatives within the CGRP antagonist class may be worth discussing:

• Ubrelvy (Ubrogepant) — Oral CGRP antagonist for acute migraine. Different delivery mechanism (tablet vs. nasal spray), but same drug class. May have different insurance coverage and pricing.
• Nurtec ODT (Rimegepant) — Orally dissolving CGRP antagonist approved for both acute treatment and migraine prevention. Dual indication may offer better value for patients needing both acute and preventive therapy.

When considering substitution, weigh the clinical reasons you chose Zavzpret in the first place. If the patient specifically needs a non-oral option (due to vomiting, gastroparesis, or preference), switching to an oral gepant may not be appropriate. Document your clinical rationale — it strengthens prior authorization appeals.

For a full comparison of alternatives, see our article on alternatives to Zavzpret.

Building Cost Conversations into Your Workflow

The most effective practices integrate cost discussions as a standard part of prescribing, not an afterthought. Here's how:

At the Point of Prescribing

1. Acknowledge cost upfront. "Zavzpret is an effective option for your migraines, but I want to make sure we address the cost. Let's look at what your insurance covers and what savings programs are available."
2. Check insurance formulary. Use your EHR's formulary lookup or a tool like Epocrates/CoverMyMeds to verify coverage before the patient leaves.
3. Provide the manufacturer savings card. Keep Pfizer Zavzpret savings card materials in your exam rooms or have your front desk distribute them with prescriptions.
4. Submit prior authorization proactively. Don't wait for the pharmacy to reject it. If PA is likely required, submit it the same day.

At Follow-Up

1. Ask about fill status. "Were you able to fill the Zavzpret prescription? Any issues with cost or availability?"
2. Troubleshoot barriers. If the patient didn't fill it, determine whether the issue was cost, availability, or prior authorization — and address it directly.
3. Reassess if needed. If cost remains insurmountable despite savings programs, discuss therapeutic alternatives rather than letting the patient go untreated.

Staff Training

• Train your prior authorization team on Zavzpret-specific requirements (most plans require documentation of triptan trial and failure).
• Ensure your pharmacy liaison knows about pharmacy stocking challenges with Zavzpret and can guide patients to pharmacies that carry it.
• Consider using Medfinder for Providers to help patients locate pharmacies with Zavzpret in stock.

Additional Resources for Your Practice

• Pfizer RxPathways: pfizerrxpathways.com — Patient assistance and savings programs
• Medfinder for Providers: medfinder.com/providers — Help patients find Zavzpret in stock at nearby pharmacies
• NeedyMeds: needymeds.org — Database of patient assistance programs
• RxAssist: rxassist.org — Comprehensive directory of pharmaceutical assistance programs

Final Thoughts

Prescribing Zavzpret is the clinical decision. Helping your patient actually afford and access it is the operational challenge that determines whether your treatment plan succeeds. By proactively integrating manufacturer savings programs, patient assistance enrollment, and cost conversations into your prescribing workflow, you can dramatically improve fill rates and treatment adherence.

The cost barrier is real — but it's manageable when you and your team know the tools available. For more resources on supporting your patients who are prescribed Zavzpret, visit Medfinder for Providers.